Seer Quick Ratio 2020-2022 | SEER
Historical quick ratio values for Seer (SEER) over the last 10 years.
| Seer Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-03-31 |
$0.45B |
$0.01B |
40.70 |
| 2021-12-31 |
$0.41B |
$0.01B |
30.36 |
| 2021-09-30 |
$0.51B |
$0.01B |
53.57 |
| 2021-06-30 |
$0.52B |
$0.01B |
62.56 |
| 2021-03-31 |
$0.54B |
$0.01B |
72.30 |
| 2020-12-31 |
$0.43B |
$0.01B |
53.44 |
| 2020-09-30 |
$0.00B |
|
0.00 |
| 2020-06-30 |
$0.00B |
|
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.559B |
$0.007B |
|
Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.
|
